Humana (HUM) director Karen W. Katz updates deferred stock unit awards
Rhea-AI Filing Summary
Humana Inc. director Karen W. Katz reported changes in her equity holdings. The filing shows a disposition of 590 shares of Humana common stock. She also reported derivative holdings in the form of restricted stock units (RSUs).
On 01/02/2026, Katz acquired 766 RSUs, which are part of her annual director’s fee payable in stock units and deferred until her resignation, when they will convert into Humana common stock on a one-for-one basis. On 12/31/2025, she acquired an additional 49 RSUs, related to dividend reinvestment on vested and deferred stock units at a price of $258.8675 per underlying share. Some director cash fees were also elected to be converted into deferred stock units, all payable in Humana common stock on a one-for-one basis upon her resignation.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 766 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 49 | $258.8675 | $13K |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Humana Common | -- | -- | -- |
Footnotes (1)
- Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
FAQ
What insider transaction did Humana (HUM) report for Karen W. Katz?
The filing shows that director Karen W. Katz reported a disposition of 590 shares of Humana common stock and updates to her restricted stock unit holdings.
How many restricted stock units did Karen W. Katz receive from Humana (HUM)?
Karen W. Katz acquired 766 restricted stock units on 01/02/2026 as part of her annual director’s fee and 49 additional RSUs on 12/31/2025 tied to dividend reinvestment on vested and deferred units.
How are Karen W. Katz’s Humana (HUM) director fees structured in this filing?
The filing explains that her annual director’s fee and certain cash fees were elected to be paid as stock units, which are deferred until her resignation and then payable in Humana common stock on a 1-for-1 basis.
What is the price associated with Karen W. Katz’s Humana (HUM) dividend reinvestment units?
The 49 restricted stock units related to dividend reinvestment on vested and deferred stock units were tied to an underlying share price of $258.8675.